4,735
Views
24
CrossRef citations to date
0
Altmetric
Review Article

Physical exercise, nutrition and hormones: three pillars to fight sarcopenia

, ORCID Icon, ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 75-88 | Received 03 Jan 2018, Accepted 06 Feb 2018, Published online: 16 Feb 2018

References

  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on Sarcopenia in older people. Age Ageing. 2010;39:412–423.
  • Jones EJ, Bishop PA, Woods AK, et al. Cross-sectional area and muscular strength: a brief review. Sports Med. 2008;38:987–994.
  • Snijders T, Parise G. Role of muscle stem cells in sarcopenia. Curr Opin Clin Nutr Metab Care. 2017;20:186–190.
  • Faulkner JA, Davis CS, Mendias CL, et al. The aging of elite male athletes: age-related changes in performance and skeletal muscle structure and function. Clin J Sport Med. 2008;18:501–507.
  • Velders M, Diel P. How sex hormones promote skeletal muscle regeneration. Sports Med. 2013;43:1089–1100.
  • Xia Z, Cholewa J, Zhao Y, et al. Targeting inflammation and downstream protein metabolism in sarcopenia: a brief up-dated description of concurrent exercise and leucine-based multimodal intervention. Front Physiol. 2017;8:434.
  • Everman S, Meyer C, Tran L, et al. Insulin does not stimulate muscle protein synthesis during increased plasma branched-chain amino acids alone but still decreases whole body proteolysis in humans. Am J Physiol Endocrinol Metab. 2016;311:E671–e677.
  • Yoon MS. The role of mammalian target of rapamycin (mTOR) in insulin signaling. Nutrients. 2017;9:1176.
  • Timmerman KL, Lee JL, Fujita S, et al. Pharmacological vasodilation improves insulin-stimulated muscle protein anabolism but not glucose utilization in older adults. Diabetes. 2010;59:2764–2771.
  • Yoon MS. The emerging role of branched-chain amino acids in insulin resistance and metabolism. Nutrients. 2016;8:405.
  • Yoon MS. mTOR as a key regulator in maintaining skeletal muscle mass. Front Physiol. 2017;8:788.
  • Galic E, Krpan D, Mirat J, et al. Diversity of bone cell activity as a histomorphometric feature of idiopathic osteoporosis in men. Aging Male. 2010;13:18–24.
  • Miller LE, Pierson LM, Pierson ME, et al. Age influences anthropometric and fitness-related predictors of bone mineral in men. Aging Male. 2009;12:47–53.
  • Liu M, Zhang Y, Cheng X, et al. The effect of age on the changes in bone mineral density and osteoporosis detection rates in Han Chinese men over the age of 50. Aging Male. 2014;17:166–173.
  • Tungjai M, Kaewjaeng S, Jumpee C, et al. Bone mineral density at distal forearm in men over 40 years of age in Mae Chaem district, Chiang Mai Province, Thailand: a pilot study. Aging Male. 2017;20:170–174.
  • Boyanov M, Bakalov D, Boneva Z. Bone mineral density in men with and without the metabolic syndrome. Aging Male. 2009;12:62–65.
  • Budui SL, Rossi AP, Zamboni M. The pathogenetic bases of sarcopenia. Clin Cases Miner Bone Metab. 2015;12:22–26.
  • Marzetti E, Calvani R, Bernabei R, et al. Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty-a mini-review. Gerontology. 2012;58:99–106.
  • Guescini M, Tiano L, Genova ML. The combination of physical exercise with muscle-directed antioxidants to counteract sarcopenia: a biomedical rationale for pleiotropic treatment with creatine and coenzyme Q10. Oxid Med Cell Longev. 2017;2017:7083049.
  • Newman AB, Haggerty CL, Goodpaster B, et al. Strength and muscle quality in a well-functioning cohort of older adults: the health, aging and body composition study. J Am Geriatr Soc. 2003;51:323–330.
  • Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the health ABC study. J Gerontol A Biol Sci Med Sci. 2002;57:M326–M332.
  • Miller MS, Bedrin NG, Callahan DM, et al. Age-related slowing of myosin actin cross-bridge kinetics is sex specific and predicts decrements in whole skeletal muscle performance in humans. J Appl Physiol. 2013;115:1004–1014.
  • Miller MS, Callahan DM, Toth MJ. Skeletal muscle myofilament adaptations to aging, disease, and disuse and their effects on whole muscle performance in older adult humans. Front Physiol. 2014;5:369.
  • Bian AL, Hu HY, Rong YD, et al. A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-alpha. Eur J Med Res. 2017;22:25.
  • Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med. 2006;61:1059–1064.
  • Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, et al. American college of sports medicine position stand. Exercise and physical activity for older adults. Med Sci Sports Exerc. 2009;41:1510–1530.
  • Suetta C, Hvid LG, Justesen L, et al. Effects of aging on human skeletal muscle after immobilization and retraining. J Appl Physiol. 2009;107:1172–1180.
  • Gianoudis J, Bailey CA, Daly RM. Associations between sedentary behaviour and body composition, muscle function and sarcopenia in community-dwelling older adults. Osteoporos Int. 2015;26:571–579.
  • Hamer M, Stamatakis E. Screen-based sedentary behavior, physical activity, and muscle strength in the English longitudinal study of ageing. PLoS One. 2013;8:e66222.
  • Ziaaldini MM, Marzetti E, Picca A, et al. Biochemical pathways of Sarcopenia and their modulation by physical exercise: a narrative review. Front Med. 2017;4:167.
  • Strasser B, Keinrad M, Haber P, et al. Efficacy of systematic endurance and resistance training on muscle strength and endurance performance in elderly adults–a randomized controlled trial. Wien Klin Wochenschr. 2009;121:757–764.
  • Peterson MD, Rhea MR, Sen A, et al. Resistance exercise for muscular strength in older adults: a meta-analysis. Ageing Res Rev. 2010;9:226–237.
  • Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American college of sports medicine and the American heart association. Med Sci Sports Exerc. 2007;39:1435–1445.
  • Chen HT, Chung YC, Chen YJ, et al. Effects of different types of exercise on body composition, muscle strength, and IGF-1 in the elderly with sarcopenic obesity. J Am Geriatr Soc. 2017;65:827–832.
  • Fry CS, Drummond MJ, Glynn EL, et al. Aging impairs contraction-induced human skeletal muscle mTORC1 signaling and protein synthesis. Skeletal Muscle. 2011;1:11.
  • Landi F, Marzetti E, Martone AM, et al. Exercise as a remedy for sarcopenia. Curr Opin Clin Nutr Metab Care. 2014;17:25–31.
  • Borde R, Hortobagyi T, Granacher U. Dose-response relationships of resistance training in healthy old adults: a systematic review and meta-analysis. Sports Med. 2015;45:1693–1720.
  • Silva NL, Oliveira RB, Fleck SJ, et al. Influence of strength training variables on strength gains in adults over 55 years-old: a meta-analysis of dose-response relationships. J Sci Med Sport. 2014;17:337–344.
  • Van Roie E, Delecluse C, Coudyzer W, et al. Strength training at high versus low external resistance in older adults: effects on muscle volume, muscle strength, and force-velocity characteristics. Exp Gerontol. 2013;48:1351–1361.
  • Van Roie E, Walker S, Van Driessche S, et al. Training load does not affect detraining’s effect on muscle volume, muscle strength and functional capacity among older adults. Exp Gerontol. 2017;98:30–37.
  • Cadore EL, Pinto RS, Bottaro M, et al. Strength and endurance training prescription in healthy and frail elderly. Aging Dis. 2014;5:183–195.
  • American College of Sports Medicine. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2009;41:687–708.
  • Lim JY. Therapeutic potential of eccentric exercises for age-related muscle atrophy. Integr Med Res. 2016;5:176–181.
  • Hoppeler H. Moderate load eccentric exercise; a distinct novel training modality. Front Physiol. 2016;7:483.
  • Aagaard P, Suetta C, Caserotti P, et al. Role of the nervous system in sarcopenia and muscle atrophy with aging: strength training as a countermeasure. Scand J Med Sci Sports. 2010;20:49–64.
  • Rogan S, de Bruin ED, Radlinger L, et al. Effects of whole-body vibration on proxies of muscle strength in old adults: a systematic review and meta-analysis on the role of physical capacity level. Eur Rev Aging Phys Act. 2015;12:12.
  • Kemmler W, Bebenek M, Engelke K, et al. Impact of whole-body electromyostimulation on body composition in elderly women at risk for sarcopenia: the training and electro stimulation trial (TEST-III). Age (Dordr). 2014;36:395–406.
  • Kern H, Barberi L, Lofler S, et al. Electrical stimulation counteracts muscle decline in seniors. Front Aging Neurosci. 2014;6:189.
  • Machado A, Garcia LD, Gonzalez-Gallego J, et al. Whole-body vibration training increases muscle strength and mass in older women: a randomized-controlled trial. Scand J Med Sci Sports. 2010;20:200–207.
  • Wei N, Pang MY, Ng SS, et al. Optimal frequency/time combination of whole-body vibration training for improving muscle size and strength of people with age-related muscle loss (sarcopenia): a randomized controlled trial. Geriatr Gerontol Int. 2016;17:1412–1420.
  • Maruya K, Asakawa Y, Ishibashi H, et al. Effect of a simple and adherent home exercise program on the physical function of community dwelling adults sixty years of age and older with pre-sarcopenia or sarcopenia. J Phys Ther Sci. 2016;28:3183–3188.
  • Di Luigi L, Rossi C, Sgro P, et al. Do non-steroidal anti-inflammatory drugs influence the steroid hormone milieu in male athletes? Int J Sports Med. 2007;28:809–814.
  • Di Luigi L, Romanelli F, Sgro P, et al. Andrological aspects of physical exercise and sport medicine. Endocrine. 2012;42:278–284.
  • Hashemi R, Motlagh AD, Heshmat R, et al. Diet and its relationship to sarcopenia in community dwelling Iranian elderly: a cross sectional study. Nutrition. 2015;31:97–104.
  • Kim J, Lee Y, Kye S, et al. Association of vegetables and fruits consumption with sarcopenia in older adults: the fourth Korea national health and nutrition examination survey. Age Ageing. 2015;44:96–102.
  • Hao J, Shen W, Yu G, et al. Hydroxytyrosol promotes mitochondrial biogenesis and mitochondrial function in 3T3-L1 adipocytes. J Nutr Biochem. 2010;21:634–644.
  • Feng Z, Bai L, Yan J, et al. Mitochondrial dynamic remodeling in strenuous exercise-induced muscle and mitochondrial dysfunction: regulatory effects of hydroxytyrosol. Free Radic Biol Med. 2011;50:1437–1446.
  • Smith GI, Atherton P, Reeds DN, et al. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr. 2011;93:402–412.
  • Di Girolamo FG, Situlin R, Mazzucco S, et al. Omega-3 fatty acids and protein metabolism: enhancement of anabolic interventions for sarcopenia. Curr Opin Clin Nutr Metab Care. 2014;17:145–150.
  • Lalia AZ, Dasari S, Robinson MM, et al. Influence of omega-3 fatty acids on skeletal muscle protein metabolism and mitochondrial bioenergetics in older adults. Aging. 2017;9:1096–1129.
  • Ticinesi A, Meschi T, Lauretani F, et al. Nutrition and inflammation in older individuals: focus on vitamin D, n-3 polyunsaturated fatty acids and whey proteins. Nutrients. 2016;8:186.
  • Dardevet D, Remond D, Peyron MA, et al. Muscle wasting and resistance of muscle anabolism: the “anabolic threshold concept” for adapted nutritional strategies during sarcopenia. Sci World J. 2012;2012:269531.
  • Cruz-Jentoft AJ. Sarcopenia: what should a pharmacist know? Farm Hosp. 2017;41:543–549.
  • Genaro Pde S, Pinheiro Mde M, Szejnfeld VL, et al. Dietary protein intake in elderly women: association with muscle and bone mass. Nutr Clin Pract. 2015;30:283–289.
  • Wall BT, van Loon LJ. Nutritional strategies to attenuate muscle disuse atrophy. Nutr Rev. 2013;71:195–208.
  • Baum JI, Kim IY, Wolfe RR. Protein consumption and the elderly: what is the optimal level of intake. Nutrients. 2016;8:359.
  • Kim IY, Deutz NEP, Wolfe RR. Update on maximal anabolic response to dietary protein. Clin Nutr. 2017;17:30203.
  • Borack MS, Volpi E. Efficacy and safety of leucine supplementation in the elderly. J Nutr. 2016;146:2625S–2629s.
  • Leenders M, van Loon LJ. Leucine as a pharmaconutrient to prevent and treat sarcopenia and type 2 diabetes. Nutr Rev. 2011;69:675–689.
  • Khor SC, Abdul Karim N, Ngah WZ, et al. Vitamin E in sarcopenia: current evidences on its role in prevention and treatment. Oxid Med Cell Longev. 2014;2014:914853.
  • Tieland M, Brouwer-Brolsma EM, Nienaber-Rousseau C, et al. Low vitamin D status is associated with reduced muscle mass and impaired physical performance in frail elderly people. Eur J Clin Nutr. 2013;67:1050–1055.
  • Kim MK, Baek KH, Song KH, et al. Vitamin D deficiency is associated with sarcopenia in older Koreans, regardless of obesity: the fourth Korea national health and nutrition examination surveys (KNHANES IV) 2009. J Clin Endocrinol Metab. 2011;96:3250–3256.
  • Alway SE, Myers MJ, Mohamed JS. Regulation of satellite cell function in sarcopenia. Front Aging Neurosci. 2014;6:246.
  • Di Luigi L. Supplements and the endocrine system in athletes. Clin Sports Med. 2008;27:131–151.
  • Ceglia L, Niramitmahapanya S, da Silva Morais M, et al. A randomized study on the effect of vitamin D3 supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. J Clin Endocrinol Metab. 2013;98:E1927–E1935.
  • Malafarina V, Uriz-Otano F, Malafarina C, et al. Effectiveness of nutritional supplementation on sarcopenia and recovery in hip fracture patients. A multi-centre randomized trial. Maturitas. 2017;101:42–50.
  • Wilson JM, Fitschen PJ, Campbell B, et al. International society of sports nutrition position stand: beta-hydroxy-beta-methylbutyrate (HMB). J Int Soc Sports Nutr. 2013;10:6.
  • Teixeira J, Chavarria D, Borges F, et al. Dietary polyphenols and mitochondrial function: role in health and disease. Curr Med Chem. 2017;24. DOI:10.2174/0929867324666170529101810
  • Alway SE, McCrory JL, Kearcher K, et al. Resveratrol enhances exercise-induced cellular and functional adaptations of skeletal muscle in older men and women. J Gerontol A Biol Sci Med. 2017; 72:1595–1606.
  • Louis M, Van Beneden R, Dehoux M, et al. Creatine increases IGF-I and myogenic regulatory factor mRNA in C(2)C(12) cells. FEBS Lett. 2004;557:243–247.
  • Hargreaves IP. Coenzyme Q10 as a therapy for mitochondrial disease. Int J Biochem Cell Biol. 2014;49:105–111.
  • Parr MK, Botre F, Nass A, et al. Ecdysteroids: a novel class of anabolic agents? Biol Sport. 2015;32:169–173.
  • Parr MK, Zhao P, Haupt O, et al. Estrogen receptor beta is involved in skeletal muscle hypertrophy induced by the phytoecdysteroid ecdysterone. Mol Nutr Food Res. 2014;58:1861–1872.
  • Ceglia L, Dawson-Hughes B, Increasing alkali supplementation decreases urinary nitrogen excretion when adjusted for same day nitrogen intake. Osteoporosis Int. 2017;28:3355–3359.
  • Ceglia L, Harris SS, Abrams SA, et al. Potassium bicarbonate attenuates the urinary nitrogen excretion that accompanies an increase in dietary protein and may promote calcium absorption. J Clin Endocrinol Metab. 2009;94:645–653.
  • Frassetto L, Morris RC Jr, Sellmeyer DE, et al. Diet, evolution and aging–the pathophysiologic effects. Eur J Nutr. 2001;40:200–213.
  • Carnauba RA, Baptistella AB, Paschoal V, et al. Diet-induced low-grade metabolic acidosis and clinical outcomes: a review. Nutrients. 2017;9:538.
  • Di Luigi L, Baldari C, Pigozzi F, et al. The long-acting phosphodiesterase inhibitor tadalafil does not influence athletes’ VO2max, aerobic, and anaerobic thresholds in normoxia. Int J Sports Med. 2008;29:110–115.
  • Glynn N, Agha A. Diagnosing growth hormone deficiency in adults. Int J Endocrinol. 2012;2012:972617.
  • Ghigo E, Aimaretti G, Corneli G, et al. Diagnosis of adult GH deficiency. Pituitary. 2008;18:1–16.
  • Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH research society in association with the European society for pediatric endocrinology, Lawson Wilkins society, European Society of endocrinology, Japan endocrine society, and endocrine society of Australia. Eur J Endocrinol. 2007;157:695–700.
  • Molitch ME, Clemmons DR, Malozowski S, et al. Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1587–1609.
  • Gasco V, Caputo M, Lanfranco F, et al. Management of GH treatment in adult GH deficiency. Best Pract Res Clin Endocrinol Metab. 2017;31:13–24.
  • Laghi F, Adiguzel N, Tobin MJ. Endocrinological derangements in COPD. Eur Respir J. 2009;34:975–996.
  • Hayashi AA, Proud CG. The rapid activation of protein synthesis by growth hormone requires signaling through mTOR. Am J Physiol Endocrinol Metab. 2007;292:E1647–E1655.
  • Appelman-Dijkstra NM, Claessen KM, Roelfsema F, et al. Long-term effects of recombinant human GH replacement in adults with GH deficiency: a systematic review. Eur J Endocrinol. 2013;169:R1–14.
  • Ehrnborg C, Ellegard L, Bosaeus I, et al. Supraphysiological growth hormone: less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults. Clin Endocrinol (Oxf). 2005;62:449–457.
  • Rubeck KZ, Bertelsen S, Vestergaard P, et al. Impact of GH substitution on exercise capacity and muscle strength in GH-deficient adults: a meta-analysis of blinded, placebo-controlled trials. Clin Endocrinol (Oxf). 2009;71:860–866.
  • Widdowson WM, Gibney J. The effect of growth hormone (GH) replacement on muscle strength in patients with GH-deficiency: a meta-analysis. Clin Endocrinol (Oxf). 2010;72:787–792.
  • Samaras N, Samaras D, Frangos E, et al. A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? Rejuvenation Res. 2013;16:285–294.
  • Corona G, Rastrelli G, Giagulli VA, et al. Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials. J Clin Endocrinol Metab. 2013;98:3615–3626.
  • Ceci R, Duranti G, Rossi A, et al. Skeletal muscle differentiation: role of dehydroepiandrosterone sulfate. Horm Metab Res. 2011;43:702–707.
  • Morales AJ, Haubrich RH, Hwang JY, et al. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol. 1998;49:421–432.
  • Rutkowski K, Sowa P, Rutkowska-Talipska J, et al. Dehydroepiandrosterone (DHEA): hypes and hopes. Drugs. 2014;74:1195–1207.
  • Villareal DT, Holloszy JO. DHEA enhances effects of weight training on muscle mass and strength in elderly women and men. Am J Physiol Endocrinol Metab. 2006;291:E1003–E1008.
  • Brown GA, Vukovich MD, Sharp RL, et al. Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men. J Appl Physiol. 1999;87:2274–2283.
  • Brown GA, Vukovich MD, Reifenrath TA, et al. Effects of anabolic precursors on serum testosterone concentrations and adaptations to resistance training in young men. Int J Sport Nutr Exerc Metab. 2000;10:340–359.
  • Timmerman KL, Dhanani S, Glynn EL, et al. A moderate acute increase in physical activity enhances nutritive flow and the muscle protein anabolic response to mixed nutrient intake in older adults. Am J Clin Nutr. 2012;95:1403–1412.
  • Sonksen P, Sonksen J. Insulin: understanding its action in health and disease. Br J Anaesth. 2000;85:69–79.
  • Fujita S, Rasmussen BB, Cadenas JG, et al. Effect of insulin on human skeletal muscle protein synthesis is modulated by insulin-induced changes in muscle blood flow and amino acid availability. Am J Physiol Endocrinol Metab. 2006;291:E745–E754.
  • Abdulla H, Smith K, Atherton PJ, et al. Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis. Diabetologia. 2016;59:44–55.
  • Kwon SS, Lee SG, Lee YH, et al. Homeostasis model assessment of insulin resistance in a general adult population in Korea: additive association of sarcopenia and obesity with insulin resistance. Clin Endocrinol. 2017;86:44–51.
  • Kim TN, Park MS, Lim KI, et al. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean sarcopenic obesity study. Clin Endocrinol (Oxf). 2013;78:525–532.
  • Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol. 2016;229:R67–R81.
  • Sabatini S, Sgro P, Duranti G, et al. Tadalafil alters energy metabolism in C2C12 skeletal muscle cells. Acta Biochimica Polonica. 2011;58:237–241.
  • Westerbacka J, Bergholm R, Tiikkainen M, et al. Glargine and regular human insulin similarly acutely enhance endothelium-dependent vasodilatation in normal subjects. Arterioscler Thromb Vasc Biol. 2004;24:320–324.
  • Tanaka K, Kanazawa I, Sugimoto T. Reduction in endogenous insulin secretion is a risk factor of sarcopenia in men with type 2 diabetes mellitus. Calcif Tissue Int. 2015;97:385–390.
  • Barzilai N, Huffman DM, Muzumdar RH, et al. The critical role of metabolic pathways in aging. Diabetes. 2012;61:1315–1322.
  • Kalyani RR, Egan JM. Diabetes and altered glucose metabolism with aging. Endocrinol Metab Clin North Am. 2013;42:333–347.
  • Tajar A, Huhtaniemi IT, O’Neill TW, et al. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European male aging study (EMAS). J Clin Endocrinol Metab. 2012;97:1508–1516.
  • Lunenfeld B, Mskhalaya G, Zitzmann M, et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male. 2015;18:5–15.
  • Huhtaniemi I. Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl. 2014;16:192–202.
  • Bhasin S, Woodhouse L, Casaburi R, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab. 2005;90:678–688.
  • Layton JB, Meier CR, Sharpless JL, et al. Comparative safety of testosterone dosage forms. JAMA Intern Med. 2015;175:1187–1196.
  • Baldari C, Di Luigi L, Emerenziani GP, et al. Is explosive performance influenced by androgen concentrations in young male soccer players? Br J Sports Med. 2009;43:191–194.
  • Kadi F, Eriksson A, Holmner S, et al. Effects of anabolic steroids on the muscle cells of strength-trained athletes. Med Sci Sports Exerc. 1999;31:1528–1534.
  • Kadi F. Cellular and molecular mechanisms responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement. Br J Pharmacol. 2008;154:522–528.
  • Sinha-Hikim I, Artaza J, Woodhouse L, et al. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab. 2002;283:E154–E164.
  • Eriksson A, Kadi F, Malm C, et al. Skeletal muscle morphology in power-lifters with and without anabolic steroids. Histochem Cell Biol. 2005;124:167–175.
  • Egner IM, Bruusgaard JC, Eftestol E, et al. A cellular memory mechanism aids overload hypertrophy in muscle long after an episodic exposure to anabolic steroids. J Physiol. 2013;591:6221–6230.
  • Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001;281:E1172–E1181.
  • Storer TW, Magliano L, Woodhouse L, et al. Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab. 2003;88:1478–1485.
  • Blazevich AJ, Giorgi A. Effect of testosterone administration and weight training on muscle architecture. Med Sci Sports Exerc. 2001;33:1688–1693.
  • Bhasin S, Travison TG, Storer TW, et al. Effect of testosterone supplementation with and without a dual 5α-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial. JAMA. 2012;307:931–939.
  • Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335:1–7.
  • Sinha-Hikim I, Roth SM, Lee MI, et al. Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab. 2003;285:E197–E205.
  • Singh R, Artaza JN, Taylor WE, et al. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology. 2003;144:5081–5088.
  • Kvorning T, Andersen M, Brixen K, et al. Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study. Am J Physiol Endocrinol Metab. 2006;291:E1325–E1332.
  • Choong K, Basaria S. Emerging cardiometabolic complications of androgen deprivation therapy. Aging Male. 2010;13:1–9.
  • Basurto L, Zarate A, Gomez R, et al. Effect of testosterone therapy on lumbar spine and hip mineral density in elderly men. Aging Male. 2008;11:140–145.
  • Kim HK, Suzuki T, Saito K, et al. Effects of exercise and amino acid supplementation on body composition and physical function in community-dwelling elderly Japanese sarcopenic women: a randomized controlled trial. J Am Geriatr Soc. 2012;60:16–23.
  • Martone AM, Marzetti E. Exercise and protein intake: a synergistic approach against Sarcopenia. BioMed Res Int. 2017;2017:2672435.
  • Martin-Fernandez M, Martinez E, Diaz-Curiel M, et al. Effects of PTH (1–84) on bone quality in a validated model of osteoporosis due to androgenic deprivation. Aging Male. 2014;17:42–50.
  • Montero M, Serfati D, Luna S, et al. The effectiveness of intermittent rat parathyroid hormone (1–34) treatment on low bone mass due to oestrogen or androgen depletion in skeletally mature rats. Aging Male. 2010;13:59–73.
  • Shigehara K, Konaka H, Koh E, et al. Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study). Aging Male. 2017;20:139–145.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.